Abstract:Abstract Mitochondrial response to inflammation is crucial in the metabolic adaptation to infection. This study aimed to explore the mitochondrial response under inflammatory and anti-inflammatory environments, with a focus on the tricarboxylic acid (TCA) cycle. Expression levels of key TCA cycle enzymes and the autophagy-related protein light chain 3b (LC3b) were determined in raw 264.7 cells treated with lipopolysaccharide (LPS) and metformin (Met). Additionally, reactive oxygen species (ROS) levels and mitochondrial membrane potential were assessed using flow cytometry. Moreover, 8-week-old C57BL/6J mice were intraperitoneally injected with LPS and Met to assess the mitochondrial response in vivo. Upon LPS stimulation, the expression of key TCA enzymes, including citrate synthase, α-ketoglutarate dehydrogenase, and isocitrate dehydrogenase 2, and the mitochondrial membrane potential decreased, whereas the levels of LC3b and ROS increased. However, treatment with Met inhibited the reduction of LPS-induced enzyme levels as well as the elevation of LC3b and ROS levels. In conclusion, the mitochondrial TCA cycle is affected by the inflammatory environment, and the LPS-induced effects can be reversed by Met treatment.

What problem does this paper attempt to address?

The problem this paper attempts to address is the investigation of the effects of inflammatory and anti-inflammatory environments on macrophage mitochondrial function, specifically the expression levels of key enzymes in the tricarboxylic acid (TCA) cycle, the expression level of the autophagy-related protein LC3b, reactive oxygen species (ROS) levels, and changes in mitochondrial membrane potential. The study explores the specific impacts of lipopolysaccharide (LPS)-induced inflammatory response and the anti-inflammatory effects of metformin (Met) on macrophage mitochondrial function through in vitro experiments (using the RAW264.7 macrophage cell line) and in vivo experiments (using the C57BL/6J mouse model). Specifically, the main questions of the study include: 1. Will the expression levels of key enzymes in the TCA cycle in macrophages change under an inflammatory environment? 2. Will ROS levels and mitochondrial membrane potential in macrophages be affected under an inflammatory environment? 3. Can metformin reverse the above changes induced by LPS? 4. Will the autophagy process in macrophages be activated under an inflammatory environment, and can metformin inhibit this activation? Through these studies, the authors hope to better understand the relationship between inflammation and macrophage mitochondrial function, providing a theoretical basis for further exploration of treatments for inflammation-related diseases.

Effects of inflammatory and anti-inflammatory environments on the macrophage mitochondrial function